FERBER & CO. Transaction announcement

Acton Mobile announced today it has entered into an agreement to acquire the mobile office fleet of Mobile Mini. The acquisition further enhances Acton Mobile’s geographic capabilities and its strategy to more effectively help customers in a wide range of in

Learning management systems have transformed over the years. The majority of organisations today are not nailing progress to a single, traditional standard such as SCORM. The Experience API, or xAPI, revolutionises how our training administrators can capture a

When starting a business from home, there are a lot of factors to consider. We have broken down the top things to think about when getting started.

Ciena® Corporation, the network specialist, has entered into a definitive agreement with TeraXion Inc. to acquire its high-speed photonics components (HSPC) assets for approximately USD $32 million (CAD $46.6 million) in cash.

A BCP will help ensure the operations continue, your staff is secure, and business assets are safe. Remember, you never know when such calamities will happen. Adequate planning can help you avoid losing revenue, customers shifting to your competitors, and incu

When cloud-based accounting software bluQube surveyed UK business leaders, five troublesome myths surrounding AI were exposed. Let’s deep dive and explore the top five misconceptions holding businesses back from implementing the innovative solution.

Certain careers pose significant health risks due to inherent job-related hazards. Safety risks such as repeated stress injuries and dangerous chemicals are frequently encountered by workers in these industries. This exposure has the potential to cause major h

Recognised in our Judges Choice Awards 2024, Flexdata LDA is a provider of exemplary technology solutions, particularly those relating to energy, communications, security, datacentres, and software systems.

Novimmune is a privately held Swiss bio-pharmaceutical company focused on the discovery, development and commercialisation of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.